Inventor · disambiguated record
Merav Bassan
Also filed as: BASSAN MERAV
10 granted patents·8 pending applications·155 citations·filing 1998–2025
89Inventor score
Files withPrilenia Neurotherapeutics Ltd7UNIV RAMOT3PRILENIA THERAPEUTICS DEV LTD2US HEALTH2BEN-AMI MIRI1
Top patents by PatentIndex Score
18 records- 0187US7264947B2Activity dependent neurotrophic factor III (ADNF III)US HEALTH·Filed 2003·Granted Sep 4, 2007·26 cites·12 claims
- 0284US10603311B2Use of pridopidine to improve cognitive function and for treating Alzheimer's diseasePrilenia Neurotherapeutics Ltd·Filed 2016·Granted Mar 31, 2020·4 cites·12 claims
- 0382US7863247B1Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptidesUNIV RAMOT·Filed 2000·Granted Jan 4, 2011·17 cites·21 claims
- 0481US6613740B1Activity dependent neurotrophic factor III (ADNF III)UNIV RAMOT·Filed 1998·Granted Sep 2, 2003·49 cites·16 claims
- 0578US2025360121A1Pridopidine for treating huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 0677US2024041855A1Modified release formulations of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 0775US10322119B2Use of pridopidine for treating Huntington's diseasePRILENIA THERAPEUTICS DEV LTD·Filed 2014·Granted Jun 18, 2019·9 cites·10 claims
- 0867US6933277B2Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptidesUNIV RAMOT·Filed 1999·Granted Aug 23, 2005·28 cites·16 claims
- 0966US12390456B2Pridopidine for treating Huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2021·Granted Aug 19, 2025·0 cites·9 claims
- 1066US6649411B2Methods of inhibiting cancer cells with ADNF III antisense oligonucleotidesUS HEALTH·Filed 1999·Granted Nov 18, 2003·22 cites·13 claims
- 1158US2009124543A1Activity dependent neurotrophic factor iii (adnf iii)US GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 1258US2025352533A1Pridopidine for treating huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 1355US11090297B2Pridopidine for treating huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2019·Granted Aug 17, 2021·0 cites·2 claims
- 1455US2009258863A1Method for treatment of amyotrophic lateral sclerosis using talampanelBEN-AMI MIRI·Filed 2009·Application pending·0 cites
- 1552US11471449B2Use of pridopidine to improve cognitive function and for treating Alzheimer's diseasePrilenia Neurotherapeutics Ltd·Filed 2019·Granted Oct 18, 2022·0 cites·17 claims
- 1652US2019209542A1Modified release formulations of pridopidinePRILENIA THERAPEUTICS DEV LTD·Filed 2018·Application pending·0 cites
- 1748US2014162954A1Fusion of human growth hormone and albumin formulation and uses thereofBROWN KURT·Filed 2013·Application pending·0 cites
- 1843US2015202302A1Modified release formulations of pridopidineLICHT DANIELLA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Merav Bassan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →